$placeNoAds is not true
placeAds(In the statement, International Class 5 is corrected per the Restriction and the fnote dated 1/21/2020;Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines * ; none of the aforesaid goods acting on the central nervous system *;, 'body') is not true
EFERMIA Brand - FindOwnerSearch

EFERMIA

Welcome to the Brand page for “EFERMIA”, which is offered here for In the statement, international class 5 is corrected per the restriction and the fnote dated 1/21/2020;pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines * ; none of the aforesaid goods acting on the central nervous system *;.

Its status is currently believed to be active. Its class is unavailable. “EFERMIA” is believed to be currently owned by “GLAXO GROUP LIMITED”.


Owner:
GLAXO GROUP LIMITED
Owner Details
Description:
In the statement, International Class 5 is corrected per the Restriction and the fnote dated 1/21/2020;Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines * ; none of the aforesaid goods acting on the central nervous system *;
Categories: STATEMENT